|
|
Changes and clinical significance of intercellular adhesion molecule-1 and eosinophils levels in patients with bronchial asthma |
ZHANG Changsheng ZHANG Haitao |
Department of Respiratory Medicine, Nanjing Brain Hospital the Affiliated Brain Hospital of Nanjing Medical University, Jiangsu Province, Nanjing 210029, China |
|
|
Abstract Objective To investigate the changes and clinical significance of intercellular adhesion molecule-1 (ICAM-1) and eosinophils (EOS) in patients with bronchial asthma. Methods From January 2012 to December 2017, a total of 86 patients with bronchial asthma treated in Nanjing Brain Hospital (“our hospital” for short) were divided into acute attack group (45 cases) and remission group (41 cases) according to their condition and symptoms. A total of 52 people undergoing health examination in our hospital at the same time were selected as control group. The levels of serum ICAM-1, EOS and pulmonary function were compared among the three groups, and the correlation was analyzed. Results The level of ICAM-1 and EOS in acute attack group and remission group were significantly higher than those in control group, while acute attack group was significantly higher than remission group, and the differences were statistically significant (P < 0.05). Maximal voluntary ventilation (MVV)/predicted value, peak expiratory flow (PEF), one second forced breath volume (FEV1) and forced vital capacity (FVC) in acute attack group and remission group were lower than those in control group, while those in acute attack group were lower than those in remission group, and the differences were statistically significant (P < 0.05). Spearman correlation results showed that ICAM-1, EOS levels were negatively correlated with FVC, FEV1 in patients with bronchial asthma(r = -0.652, -0.548; r = -0.549, -0.598, P < 0.05). Conclusion ICAM-1 and EOS may be involved in the occurrence and development of bronchial asthma. The analysis of ICAM-1 content and EOS count have important clinical significance for the diagnosis and treatment of bronchial asthma.
|
|
|
|
|
[1] Michalik M,Wójcik-Pszczo?覥a K,Paw M,et al. Fibroblast-to-myofibroblast transition in bronchial asthma [J]. Cell Mol Life Sci,2018,75(21):3943-3961.
[2] Liu Y,Zhang H,Ni R,et al. IL-4R suppresses airway inflammation in bronchial asthma by inhibiting the IL-4/STAT6 pathway [J]. Pulm Pharmacol Ther,2017,43(1):32-38.
[3] Zhu J,Liu X,Wang W,et al. Altered expression of regulatory T and Th17 cells in murine bronchial asthma [J]. Exp Ther Med,2017,14(1):714-722.
[4] Jiang XG,Yang XD,Lv Z,et al. Elevated serum levels of TNF-α,IL-8,and ECP can be involved in the development and progression of bronchial asthma [J]. J Asthma,2017,55(2):111-118.
[5] 吕平,彭万胜,董淮富.新型抑制性细胞因子IL-35与支气管哮喘的研究进展[J].中国临床药理学与治疗学,2018,23(2):230-234.
[6] 石超.支气管哮喘患儿诱导痰液中细胞间黏附分子-1、血管内皮生长因子表达水平与哮喘病情严重程度及气道炎症的关系[J].中国卫生检验杂志,2017,27(22):3292-3293.
[7] 张志海,陈嘉馨,谭慧锋,等.探讨支气管哮喘急性发作患者诱导痰嗜酸性粒细胞比例变化及肺功能的关系[J].数理医药学杂志,2017,30(7):1007-1008.
[8] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志,2008,31(3):177-185.
[9] Carotenuto M,Perfetti L,Calcagno MG,et al. Comparison Of Acute Bronchodilator Effects Of Inhaled Ipratropium Bromide And Salbutamol In Adults With Bronchial Asthma [J]. J Allergy Clin Immunol,2018,141(2):209.
[10] Li XE,Yan G,HaoS G,et al. Analysis of montelukast in combined with extended care applied in children with bronchial asthma [J]. J Hainan Med University,2017,23(1):151-153.
[11] 尹艺晓,张发艳,周生余.PAR激活在哮喘发生中作用机制的研究进展[J].山东医药,2018(3):101-104.
[12] 张佳佳,胡赤军,周小勤,等.布地奈德联合孟鲁司特钠对支气管哮喘患儿细胞因子、免疫功能影响[J].现代生物医学进展,2017,17(3):159-162.
[13] 白松,崔玉琳,柴若楠,等.CD4+T细胞通过分泌Th2型细胞因子介导RSV感染所诱发的气道炎性反应[J].中华微生物学和免疫学杂志,2017,37(10):747-752.
[14] Wyatt T,Canady K,Heires A,et al. Alcohol Inhibits Organic Dust-induced ICAM-1 Expression on Bronchial Epithelial Cells [J]. Safety,2017,3(1):5-19.
[15] Yan Y,Bao HP,Li CL,et al. Wentong decoction cures allergic bronchial asthma by regulating the apoptosis imbalance of EOS [J]. Chin Med,2018,13(1):21-31.
[16] 石超.支气管哮喘患儿诱导痰液中细胞间黏附分子-1、血管内皮生长因子表达水平与哮喘病情严重程度及气道炎症的关系[J].中国卫生检验杂志,2017,27(22):3292-3293.
[17] 吴思仿,周丽芹,吴峰.支气管哮喘患者ICAM-1、EOS水平与病情严重程度的相关性分析[J].临床肺科杂志,2019,24(5):34-37.
[18] 周洁,吉玲,王新华,等.细胞间黏附分子-1在支气管哮喘儿童支气管黏膜中的表达及其对支气管上皮细胞凋亡的影响[J].新乡医学院学报,2019,36(2):31-35.
[19] 孙林,胡三强,宋传涛.儿童感染性肺炎患者血液中炎症因子,ECP,EOS,IgE,VEGF及其受体检测与临床意义分析[J].现代检验医学杂志,2018,33(1):121-123.
[20] 白雪,秦光梅,胡红,等.呼出气一氧化氮、外周血嗜酸性粒细胞及血清总IgE在Eos型哮喘诊断中的意义[J].疑难病杂志,2017,16(9):889-894.
[21] 孙婕怡,胥冰.IL-17、IgE在支气管哮喘患儿血清中的浓度变化及其临床意义[J].临床医学研究与实践,2017, 2(17):49-50.
[22] 冯国飞,尤慧华,王珊,等.血清趋化因子、细胞间黏附分子、嗜酸细胞阳离子蛋白及相应细胞因子在变应性鼻炎患者中的表达水平分析[J].中国卫生检验杂志,2017, 16(9):1128-1130. |
|
|
|